acedapsone has been researched along with Leprosy in 17 studies
*Leprosy: A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (70.59) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Bera, S; Mondal, D | 1 |
| George, J | 1 |
| Christian, M; Jesudasan, K; Kurian, N; Rao, GS; Shaw, IN | 1 |
| Ellard, GA | 1 |
| Keeler, RF | 1 |
| Neelan, PN; Noordeen, SK; Sivaprasad, N | 1 |
| Munaf, A; Neelan, PN; Noordeen, SK | 1 |
| Desikan, KV; Ramu, G; Sengupta, U | 1 |
| Blanc, LJ | 1 |
| Smith, CM; Smith, WC | 1 |
| Fasal, P; Jano, B; Russell, DA; Shepard, CC; Worth, RM | 2 |
| Anand, LC; Rathore, BS | 1 |
| Levy, L; Peters, JH | 1 |
| Gordon, GR; Levy, L; Murray, JF; Peters, JH; Russell, DA; Scott, GC; Shepard, CC; Vincin, DR | 1 |
| Iyer, CG; Ramanujam, K; Ramu, G | 1 |
| Levy, L; Shepard, CC | 1 |
3 review(s) available for acedapsone and Leprosy
| Article | Year |
|---|---|
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Metabolism and interactions of antileprosy drugs.
Topics: Acedapsone; Biological Availability; Biotransformation; Clofazimine; Cytochrome P-450 CYP3A; Dapsone; Drug Interactions; Drug Therapy, Combination; Half-Life; Humans; Leprostatic Agents; Leprosy; Metabolic Clearance Rate; Metabolic Networks and Pathways; Mycobacterium leprae; Rifampin | 2020 |
Chemoprophylaxis is effective in the prevention of leprosy in endemic countries: a systematic review and meta-analysis. MILEP2 Study Group. Mucosal Immunology of Leprosy.
Topics: Acedapsone; Clinical Trials as Topic; Cost-Benefit Analysis; Dapsone; Humans; Leprostatic Agents; Leprosy; Rifampin; Risk Factors; Topography, Medical | 2000 |
6 trial(s) available for acedapsone and Leprosy
| Article | Year |
|---|---|
Multidrug therapy for leprosy in Trinidad and Tobago: a preliminary report.
Topics: Acedapsone; Adolescent; Adult; Aged; Child; Child, Preschool; Clinical Trials as Topic; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Leprosy; Male; Middle Aged; Rifampin; Trinidad and Tobago | 1984 |
Chemoprophylaxis against leprosy with acedapsone.
Topics: Acedapsone; Adolescent; Age Factors; Child; Child, Preschool; Dapsone; Female; Humans; Infant; Leprosy; Male; Sex Factors | 1983 |
Chemoprophylaxis against leprosy with acedapsone. An interim report.
Topics: Acedapsone; Adolescent; Age Factors; Child; Child, Preschool; Clinical Trials as Topic; Dapsone; Double-Blind Method; Female; Humans; India; Infant; Leprosy; Male; Time Factors | 1980 |
Susceptibility of Mycobacterium leprae to dapsone as a determinant of patient response to acedapsone.
Topics: Acedapsone; Animals; Clinical Trials as Topic; Dapsone; Humans; Injections, Intramuscular; Leprosy; Mice; Mycobacterium leprae; Time Factors | 1976 |
A preliminary report on a therapeutic trial with acedapsone in lepromatous leprosy.
Topics: Acedapsone; Adult; Clinical Trials as Topic; Dapsone; Humans; Leprosy; Male | 1975 |
The number of Mycobacterium leprae in the pretreatment biopsy-specimen does not determine the rate of response of patients with lepromatous leprosy to chemotherapy with acedapsone.
Topics: Acedapsone; Animals; Clinical Trials as Topic; Dapsone; Drug Evaluation; Humans; Leprosy; Mice; Mycobacterium leprae; Random Allocation; Skin | 1986 |
8 other study(ies) available for acedapsone and Leprosy
| Article | Year |
|---|---|
Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Topics: Acedapsone; Adult; Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy; Male; Rifampin; Skin; Treatment Outcome; World Health Organization | 2003 |
Combined treatment for lepromatous leprosy.
Topics: Acedapsone; Animals; Dapsone; Drug Therapy, Combination; Ethionamide; Humans; Leprostatic Agents; Leprosy; Mice; Prothionamide; Rifampin; Thioacetazone | 1980 |
Influence of sulphone therapy on lepromin reaction.
Topics: Acedapsone; Adult; Dapsone; Humans; Lepromin; Leprosy | 1980 |
Trials of preventive therapy.
Topics: Acedapsone; Chemoprevention; Clinical Trials as Topic; Dapsone; Humans; India; Leprostatic Agents; Leprosy; Pacific Islands; Rifampin | 1999 |
Letter: Prevention of leprosy by acedapsone.
Topics: Acedapsone; Adult; Child; Dapsone; Humans; Leprosy; Micronesia | 1975 |
Acedapsone in the prevention of leprosy: field trial in three high prevalence villages in Micronesia.
Topics: Acedapsone; Adult; Child; Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Micronesia; Patient Compliance; Recurrence | 1979 |
Activity and effective serum level of repository sulphones (DADDS) in lepromatous leprosy.
Topics: Acedapsone; Adult; Dapsone; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Leprosy; Male; Middle Aged | 1979 |
Acedapsone treatment of leprosy patients: response versus drug disposition.
Topics: Acedapsone; Acetylation; Adult; Child; Dapsone; Female; Humans; Leprosy; Male; Phenotype; Sulfamethazine | 1977 |